Mckesson Corporation

Mckesson Corporation, doing business as Mckesson Drug Company, is a for-profit pharmaceutical and medical supply distributor that operates as a prime contractor delivering prescription medications, bulk pharmaceuticals, and clinical pharmacy supplies to federal civilian and military healthcare agencies. The company competes on full-and-open basis across all its federal work, with no SBA set-aside designations in its footprint.

Mckesson's federal portfolio centers on pharmaceutical supply chain and logistics. The vendor holds massive prime vendor and open-market BPA contracts with the Department of Health and Human Services' Indian Health Service to furnish pharmaceutical products not available through the Department of Veterans Affairs' primary distribution network, supporting healthcare delivery to Native American populations. Recent representative work includes a $5.8 million definitive contract (awarded March 2023) to sustain 266,000 vials of penicillin G potassium for the Strategic National Stockpile through the Office of the Assistant Secretary for Preparedness and Response, and multiple BPA calls ranging from $15,000 to $424,000 with IHS for open-market clinical pharmacy supplies, penicillin injections, alvimopan capsules, and medical/surgical supplies across regional service units in Arizona, Montana, New Mexico, and Utah. Mckesson also fulfills emergency pharmaceutical procurement for the Department of Veterans Affairs Veterans Health Administration regional networks, including a $56,559 emergency order of alvimopan capsules (January 2024) and multiple sub-$50,000 purchase orders for specialty medications such as varenicline tartrate and relizorb cartridges.

Customer concentration is extreme and skewed by award count versus dollar magnitude. The Defense Logistics Agency Troop Support Medical accounts for 379,561 awards worth $74.91 billion combined potential value — nearly 85% of all dollars. The Indian Health Service accounts for 156 awards worth $26.4 million (0.03% of total potential value), and the VA's Veterans Health Administration regional service networks account for another roughly 500 awards in the $1.6 million to $3.4 million range per network. This concentration reflects Mckesson's role as a prime vendor on large indefinite-delivery vehicles serving military treatment facilities through the DLA supply chain and smaller BPA-driven work supporting civilian agencies.

Mckesson places task orders under five major parent vehicles: the SPM2DX13D1000 IDC (209,462 task orders, $12.28 billion), the SPE2DX16D1500 IDC (154,494 task orders, $10.99 billion), the SPE2DX19D1501 IDC (8,928 task orders, $737 million), the SPM20003D1675 IDC (6,673 task orders, $894.1 million), and the PC049048 BPA (808 task orders, $1.5 million). The first two vehicles account for the overwhelming majority of Mckesson's federal pharmaceutical supply work and form the backbone of military medical logistics.

Mckesson's award portfolio shows extreme concentration by category. Of 381,386 prime awards, 372,938 fall under NAICS 325412 (Medicinal and Botanical Manufacturing), 7,017 under NAICS 424210 (Drugs and Druggists' Sundries Merchant Wholesalers), and 301 under NAICS 325412 (Pharmaceutical Preparation Manufacturing). By PSC code, 380,476 awards carry PSC 6505 (Drugs and Biologicals), with 771 under PSC 6500 (Medical and Surgical Instruments, Equipment, and Supplies). The source data spans from July 2001 to December 2024, showing a recent slowdown in award activity (77 awards in 2023, 40 in 2024 versus 44,000–77,000 annually through 2022), though the dollar value potential remains at $88.97 billion across all 381,386 awards. Combined dollars obligated sit at $24.96 billion (28% utilization), consistent with indefinite-delivery vehicle structures where ceilings exceed actual spending.

Mckesson Corporation, headquartered in Irving, Texas, serves as the parent entity. The child vendor registrations under Mckesson Drug Company reference the same location and perform identically across the federal footprint — no distinct operational subsidiaries are evident in the award data. The pharmaceutical and medical supply distribution business is Mckesson's sole federal mission across both the prime and civilian healthcare sides.